SKYE
Skye Bioscience, Inc. Common Stock
stockNASDAQ
Market OpenNov 10, 2026 10:44:35 AM EST
0.77USD+11.594%(+0.08)1,460,292
Pre-marketNov 10, 2026 9:27:30 AM EST
0.7507USD+8.797%(+0.0607)
Loading…
Loading…
3.37M
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$0.76
Beta
0.69
52-Week High
$12.72 2025-11-12
52-Week Low
$0.50 2026-11-09
SMA 50
$1.61
SMA 200
$4.65
Avg. Vol 10D
32,993
Avg. Vol 30D
29,862
Avg. Vol 90D
70,639
Relative Vol
42.49
4.43M
2.98M
67.24%
140,313
4.71%
4.90
40%/60%
27.16%
21.63%
3.1900%
55,000
4,747
4,114
11,591
Aug 24, 2026 · 1-for-8 (reverse)
-50.5M
-10.18
-38.8M
-233.87
Oct 21, 2026
Sep 25, 2026
Sep 18, 2026
5am Partners VII, LLC sells $64,733 in Skye Bioscience stock · 
Investing.com
Skye Bioscience director Andrew Schwab sells $64,733 in shares · Investing.com
SKYE Profile
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
SKYE Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.22 | 2026-11-03 | -37.70% | -1.665 |
| 1M | 1.69 | 2026-10-09 | -55.03% | -1.297 |
| 3M | 4.26 | 2026-08-10 | -82.16% | -0.743 |
| 6M | 7.04 | 2026-05-11 | -89.20% | -0.146 |
| 1Y | 11.36 | 2025-11-10 | -93.31% | 0.685 |
| 2Y | 44.00 | 2024-11-11 | -98.27% | — |
| 5Y | 104.00 | 2021-12-31 | -99.27% | 0.294 |
SKYE Stock Summary
Skye Bioscience, Inc. Common Stock (NASDAQ:SKYE) stock price today is $0.76, and today's volume is 1,268,826. SKYE is up 10.145% today. The 30 day average volume is 29,862. SKYE market cap is $3.37M with 4.43M shares outstanding.